NO20054472L - 2-(butyl-1-sulfonylamino)-N-[1(R)-(6-metoksy-pyridin-3-yl)-propyl]-benzamid, dets anvendelse som medikament samt farmasoytiske preparater inneholdende forbindelsen - Google Patents
2-(butyl-1-sulfonylamino)-N-[1(R)-(6-metoksy-pyridin-3-yl)-propyl]-benzamid, dets anvendelse som medikament samt farmasoytiske preparater inneholdende forbindelsenInfo
- Publication number
- NO20054472L NO20054472L NO20054472A NO20054472A NO20054472L NO 20054472 L NO20054472 L NO 20054472L NO 20054472 A NO20054472 A NO 20054472A NO 20054472 A NO20054472 A NO 20054472A NO 20054472 L NO20054472 L NO 20054472L
- Authority
- NO
- Norway
- Prior art keywords
- sulfonylamino
- benzamide
- pyridin
- methoxy
- propyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10312073A DE10312073A1 (de) | 2003-03-18 | 2003-03-18 | 2-(Butyl-1-sulfonylamino)-N-[1(R)-(6-methoxy-pyridin-3yl)-propyl]-benzamid, dessen Verwendung als Medikament sowie dieses enthaltende pharmazeutische Zubereitungen |
| PCT/EP2004/002247 WO2004083157A1 (de) | 2003-03-18 | 2004-03-05 | 2-(butyl-1-sulfonylamino)-n-[1(r)-(6-methoxy-pyridin-3-yl)-propyl]-benzamid, dessen verwendung als medikament sowie dieses enthaltende pharmazeutische zubereitungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20054472L true NO20054472L (no) | 2005-09-27 |
Family
ID=32920928
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20054472A NO20054472L (no) | 2003-03-18 | 2005-09-27 | 2-(butyl-1-sulfonylamino)-N-[1(R)-(6-metoksy-pyridin-3-yl)-propyl]-benzamid, dets anvendelse som medikament samt farmasoytiske preparater inneholdende forbindelsen |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP1606237A1 (sr) |
| JP (1) | JP2006520343A (sr) |
| KR (1) | KR20050110681A (sr) |
| CN (1) | CN100361943C (sr) |
| AR (1) | AR043622A1 (sr) |
| AU (1) | AU2004222137A1 (sr) |
| BR (1) | BRPI0408441A (sr) |
| CA (1) | CA2519022A1 (sr) |
| DE (1) | DE10312073A1 (sr) |
| HK (1) | HK1086819A1 (sr) |
| HR (1) | HRP20050815A2 (sr) |
| MA (1) | MA27749A1 (sr) |
| MX (1) | MXPA05009763A (sr) |
| MY (1) | MY176510A (sr) |
| NO (1) | NO20054472L (sr) |
| NZ (1) | NZ542476A (sr) |
| PE (1) | PE20050307A1 (sr) |
| RS (1) | RS20050690A (sr) |
| RU (1) | RU2333202C2 (sr) |
| TW (1) | TW200500342A (sr) |
| WO (1) | WO2004083157A1 (sr) |
| ZA (1) | ZA200506328B (sr) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102004009931A1 (de) * | 2004-02-26 | 2005-09-15 | Aventis Pharma Deutschland Gmbh | Kv1.5-Blocker zur selektiven Steigerung der Vorhofkontraktilität und Behandlung der Herzinsuffizienz |
| US7569589B2 (en) | 2004-07-29 | 2009-08-04 | Merck & Co., Inc. | Potassium channel inhibitors |
| DE102005028845A1 (de) * | 2005-06-22 | 2006-12-28 | Sanofi-Aventis Deutschland Gmbh | Substituierte Heterocyclen, ihre Verwendung als Medikament sowie enthaltende pharmazeutische Zubereitungen |
| WO2007015775A2 (en) * | 2005-07-22 | 2007-02-08 | Merck & Co., Inc. | Potassium channel inhibitors |
| JP5685203B2 (ja) | 2009-05-29 | 2015-03-18 | ラクオリア創薬株式会社 | カルシウムチャネル遮断薬またはナトリウムチャネル遮断薬としてのアリール置換カルボキサミド誘導体 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10121003A1 (de) * | 2001-04-28 | 2002-12-19 | Aventis Pharma Gmbh | Anthranilsäureamide, Verfahren zur Herstellung, ihrer Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen |
-
2003
- 2003-03-18 DE DE10312073A patent/DE10312073A1/de not_active Withdrawn
-
2004
- 2004-03-05 CA CA002519022A patent/CA2519022A1/en not_active Abandoned
- 2004-03-05 EP EP04717628A patent/EP1606237A1/de not_active Withdrawn
- 2004-03-05 KR KR1020057017498A patent/KR20050110681A/ko not_active Application Discontinuation
- 2004-03-05 RS YUP-2005/0690A patent/RS20050690A/sr unknown
- 2004-03-05 AU AU2004222137A patent/AU2004222137A1/en not_active Abandoned
- 2004-03-05 JP JP2006504553A patent/JP2006520343A/ja not_active Abandoned
- 2004-03-05 RU RU2005132163/04A patent/RU2333202C2/ru not_active IP Right Cessation
- 2004-03-05 NZ NZ542476A patent/NZ542476A/en unknown
- 2004-03-05 PE PE2004000245A patent/PE20050307A1/es not_active Application Discontinuation
- 2004-03-05 MX MXPA05009763A patent/MXPA05009763A/es active IP Right Grant
- 2004-03-05 WO PCT/EP2004/002247 patent/WO2004083157A1/de active Application Filing
- 2004-03-05 BR BRPI0408441-1A patent/BRPI0408441A/pt not_active IP Right Cessation
- 2004-03-05 CN CNB2004800060168A patent/CN100361943C/zh not_active Expired - Fee Related
- 2004-03-16 AR ARP040100866A patent/AR043622A1/es unknown
- 2004-03-16 TW TW093106899A patent/TW200500342A/zh unknown
- 2004-03-17 MY MYPI20040938A patent/MY176510A/en unknown
-
2005
- 2005-08-08 ZA ZA200506328A patent/ZA200506328B/en unknown
- 2005-09-16 HR HR20050815A patent/HRP20050815A2/xx not_active Application Discontinuation
- 2005-09-19 MA MA28502A patent/MA27749A1/fr unknown
- 2005-09-27 NO NO20054472A patent/NO20054472L/no not_active Application Discontinuation
-
2006
- 2006-06-16 HK HK06106891A patent/HK1086819A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| HK1086819A1 (en) | 2006-09-29 |
| MY176510A (en) | 2020-08-12 |
| RU2005132163A (ru) | 2006-04-10 |
| DE10312073A1 (de) | 2004-09-30 |
| PE20050307A1 (es) | 2005-06-08 |
| CN1756728A (zh) | 2006-04-05 |
| CN100361943C (zh) | 2008-01-16 |
| NZ542476A (en) | 2008-05-30 |
| KR20050110681A (ko) | 2005-11-23 |
| TW200500342A (en) | 2005-01-01 |
| ZA200506328B (en) | 2006-04-26 |
| CA2519022A1 (en) | 2004-09-30 |
| HRP20050815A2 (en) | 2006-09-30 |
| RU2333202C2 (ru) | 2008-09-10 |
| EP1606237A1 (de) | 2005-12-21 |
| AR043622A1 (es) | 2005-08-03 |
| MXPA05009763A (es) | 2006-01-27 |
| AU2004222137A1 (en) | 2004-09-30 |
| BRPI0408441A (pt) | 2006-04-04 |
| RS20050690A (sr) | 2008-04-04 |
| JP2006520343A (ja) | 2006-09-07 |
| WO2004083157A1 (de) | 2004-09-30 |
| MA27749A1 (fr) | 2006-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20051600L (no) | 1,4-disubstituerte piperidinderivater og anvendelse derav som 11-betaHSD1 inhibitorer | |
| NO20051036L (no) | 3,4-disubstituerte syklobuten-1,2-dioner som CXC-kjemokinreseptorligander | |
| NO950297L (no) | Prolinamidderivater | |
| NO944911L (no) | Ikke-peptid-takykininreseptorantagonister | |
| HK1048989B (zh) | 雜環衍生物及其醫藥用途 | |
| NO20060147L (no) | Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav | |
| CA2296604A1 (en) | Crystal modification of a n-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use | |
| NO331013B1 (no) | Nye forbindelser som er anti-inflammasjons, immunomodulerende og anti-proliferative midler, anvendelse av forbindelsene samt farmasoytisk preparat | |
| NO20052182L (no) | Nye forbindelser | |
| NO20054472L (no) | 2-(butyl-1-sulfonylamino)-N-[1(R)-(6-metoksy-pyridin-3-yl)-propyl]-benzamid, dets anvendelse som medikament samt farmasoytiske preparater inneholdende forbindelsen | |
| NO20040881L (no) | Orale antidiabetes midler. | |
| GEP20053505B (en) | Diphenyl Ether Compounds Useful in Therapy | |
| NO20044091L (no) | Anvendelse av substituerte 3-fenyl-5-alkoksy-1,3,4-oksdiazol-2-on for fremstilling av medikamenter som inhiberer pankreatisk lipase | |
| DE3785393T2 (de) | 4-(aroylamino)piperidinbutanamide derivate. | |
| NO20013601L (no) | Nye morfolinobenzamidsalter | |
| IL149306A0 (en) | Benzamidine derivatives and pharmaceutical compositions containing the same | |
| ES2147499A1 (es) | Derivados de acidos carboxilicos, metodo para su elaboracion y agentes terapeuticos que contienen estos compuestos. | |
| HK1083839A1 (en) | Indoline compound and medicinal use thereof | |
| AU5233896A (en) | Use of (alpha-aminomethyl-3,4-dichlorobenzyl) thioacetamide derivatives for inhibiting dopamine reuptake and new compounds for this use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |